21 completed, 6 terminated, 5 unknown, 2 active not recruiting. 36 Phase 3, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 36 | Completed 21, Terminated 6, Unknown 5, Active not recruiting 2, Recruiting 2 |
| Phase 2 | 10 | Completed 7, Recruiting 1, Terminated 1, Unknown 1 |
Follow Fish Oils: new trials by email Literature Review of Fish Oils trials Research Report on Fish Oils
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo life'sTM omega O1035DS nTG, life'sTM omega O3020DS nTG, MEG-3 3323rTG - Absorption of Omega-3, Omega-3 Supplementation | Phase 3 | Completed | RDC Clinical Pty Ltd | 120 | 2025-10-27 | 2026-09-09 |
| Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome Fish oil, Probiotics, Prebiotics - Perinatal Depression, PerinatalAnxiety | Phase 2 / Phase 3 | Recruiting | The Canadian College of Naturopathic Medicine | 100 | 2024-08-15 | 2024-08-27 |
| Poly-unsaturated Fats for Improving Nasal Polyps and Asthma Fish oil, Placebo - Asthma | Phase 3 | Completed | Norfolk and Norwich University Hospitals NHS Foundation Trust | 18 | 2023-10-09 | 2026-06-08 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III Vitamin D3 Drops, Coriolus Versicolor, Trident SAP 66:33 Lemon - Lung Cancer, Gastric Cancer | Phase 3 | Recruiting | Ottawa Hospital Research Institute | 20 | 2022-04-04 | 2026-01-30 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus ORMD-0801, Placebo - T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Terminated | Oramed, Ltd. | 346 | 2021-03-16 | 2023-02-09 |
| Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Placebo, ORMD-0801 QD, ORMD-0801 BD - Type 2 Diabetes Mellitus | Phase 3 | Terminated | Oramed, Ltd. | 710 | 2020-12-15 | 2023-02-09 |
| Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis Omega-3 polyunsaturated fatty acids, Aspirin, Placebo - Aggressive Periodontitis | Phase 2 / Phase 3 | Completed | Universidade Estadual Paulista Júlio de Mesquita Filho | 38 | 2017-05-15 | 2021-12-28 |
| Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis Open flap debridement, Placebo, Omega-3 polyunsaturated fatty acids - Residual Disease, Aggressive Periodontitis | Phase 2 / Phase 3 | Completed | Universidade Estadual Paulista Júlio de Mesquita Filho | 34 | 2017-05-15 | 2020-11-17 |
| Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL Vitamin D3 (cholecalciferol), fish oil - Aging | Phase 3 | Unknown | Augusta University | 1054 | 2016-08-19 | 2020-05-13 |
| Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives Vitamin D3, Omega-3 Fatty acids, Vitamin D3 placebo - Hypertension, Kidney Diseases | Phase 3 | Completed | Albert Einstein College of Medicine | 2232 | 2016-04-01 | 2024-05-31 |
| Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients Fingolimod, Fish Oil, Placebo (for Fish Oil) - Multiple Sclerosis | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 50 | 2015-04-01 | 2019-05-14 |
| Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function soybean oil (SO)-based IVFE (Medialipide), fish oil (FO)-containing IVFE (Lipidem) - Intestinal Diseases | Phase 3 | Terminated | Hospices Civils de Lyon | 13 | 2015-01-01 | 2018-02-28 |
| Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure Vitamin D and fish oil, Fish oil (EPA/DHA) alone, Vitamin D alone - Heart Failure | Phase 3 | Completed | Brigham and Women's Hospital | 25871 | 2014-08-01 | 2022-03-18 |
| Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. omega-3 PUFAs, Standard care, placebo - 22q11 Deletion Syndrome | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 80 | 2014-06-01 | 2014-02-25 |
| Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders Fish Oil, Safflower Oil - Epilepsy (Treatment Refractory) | Phase 2 / Phase 3 | Terminated | The Canadian College of Naturopathic Medicine | 6 | 2013-01-01 | 2023-02-10 |
| Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence Omega 3, Placebo - Tobacco Dependence, Nicotine Dependence | Phase 3 | Completed | Federal University of São Paulo | 58 | 2013-01-01 | 2020-10-14 |
| VITAL Rhythm Study Vitamin D3, Omega-3 fatty acids (fish oil), Fish oil placebo - Cardiovascular Disease | Phase 3 | Active not recruiting | Brigham and Women's Hospital | 25119 | 2012-10-01 | 2025-10-07 |
| A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer Dietary supplementation with fish oil., Dietary supplementation with vegetable oil - Metastatic Breast Cancer, Progesterone Receptor Positive Tumor | Phase 3 | Terminated | University Hospital, Tours | 65 | 2012-02-01 | 2015-07-29 |
| Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)? omega 3 - Coronary Arteriosclerosis | Phase 3 | Unknown | Shiraz University of Medical Sciences | 90 | 2012-02-01 | 2013-01-29 |
| Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition Soybean oil (Standard treatment), Soybean oil + Fish oil - Total Parenteral Nutrition-induced Cholestasis | Phase 3 | Terminated | Johane Allard | 2 | 2012-02-01 | 2016-05-12 |
Showing 20 of 36. Sign in to see all of them.
Cardiovascular Diseases (5) · Diabetes Mellitus, Type 2 (3) · Hyperphagia (3) · Inflammation (3) · Aggressive Periodontitis (2) · Coronary Artery Disease (2) · Dyslipidemias (2) · Epilepsy (2) · Insulin Resistance (2) · 22q11 Deletion Syndrome (1) · Acquired Immunodeficiency Syndrome (1) · Anorexia (1) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Asthma (1)
Brigham and Women's Hospital (5) · The Canadian College of Naturopathic Medicine (3) · Oramed, Ltd. (2) · Universidade Estadual Paulista Júlio de Mesquita Filho (2) · Albert Einstein College of Medicine (1) · Augusta University (1) · Bambino Gesù Hospital and Research Institute (1) · Cedars-Sinai Medical Center (1) · Federal University of São Paulo (1) · Hospices Civils de Lyon (1) · Instituto Mexicano del Seguro Social (1) · Isfahan University of Medical Sciences (1) · Johane Allard (1) · Johann Wolfgang Goethe University Hospital (1) · Johns Hopkins University (1)
United States (14) · Canada (6) · Brazil (3) · Australia (2) · France (2) · Iran (2) · Germany (1) · Holy See (1) · United Kingdom (1)
Mauro Santamaria, Professor (2) · Miriam Kidron, PhD (2) · Andrew Seely, MD, PhD, FRCSC (1) · Andrew Wilson (1) · Anne Birkett (1) · Aruna Pradhan, MD, MPH (1) · Christine M. Albert, M.D., M.P.H. (1) · Dick C Chan, PhD (1) · Didier Barnoud, MD (1) · Dugald Seely, ND (1) · Dugald Seely, ND, MSc (1) · Edgar R Miller, MD (1)
PMID 33724323, PMID 37454148, PMID 19116237, PMID 22136963, PMID 23134549, PMID 23275364, PMID 23630244, PMID 24252845, PMID 24451612, PMID 25195547, PMID 29526608, PMID 31669447, PMID 31699704, PMID 31733345, PMID 31895658, PMID 31923341, PMID 32205068, PMID 32749491, PMID 33206192, PMID 33513226, PMID 34366734, PMID 34543425, PMID 34612056, PMID 34678177, PMID 34853363, PMID 34932079, PMID 35082139, PMID 35361440, PMID 36044209, PMID 36098968, PMID 36285795, PMID 36378553, PMID 36416841, PMID 37212116, PMID 37267732, PMID 37468189, PMID 37878483, PMID 37952113, PMID 38018439, PMID 38113446, PMID 38272846, PMID 39171074, PMID 39488682, PMID 39618688, PMID 40032221, PMID 40199888, PMID 40409468, PMID 42630947
R01CA138962 (1), R01DK088078 (1), R01DK102952 (1), R01HL116690 (1), R01HL131674 (1), R21AT002901 (1), U01CA138962 (1)